Toxicocinétique des substances chimiques In: Encyclopédie Médico-Chirurgicale, Editions Techniques, pp.16-17, 1995. ,
-tetrachlorodibenzo-p- dioxin alters reproductive development of female Long Evans hooded rat offspring, utero exposure to low doses of 2, pp.237-281, 1997. ,
URL : https://hal.archives-ouvertes.fr/jpa-00209836
A Generic Toxicokinetic Model for Persistent Lipophilic Compounds in Humans: An Application to TCDD, Toxicological Sciences, vol.31, issue.1, pp.83-94, 1996. ,
DOI : 10.1093/toxsci/31.1.83
Data on kinetics of PCDDs and PCDFs as a prerequisite for human risk assessment, Biological Basis for Risk Assessments of Dioxins and Related Compounds, pp.215-243, 1991. ,
-tetrachlorodibenzo-p- dioxin in Vietnam veterans of Operation Ranch Hand, Journal of Toxicology and Environmental Health, vol.237, issue.27, pp.165-71, 1989. ,
URL : https://hal.archives-ouvertes.fr/hal-01442568
Determinants of TCDD half???life in veterans of operation ranch hand, Journal of Toxicology and Environmental Health, vol.37, issue.4, pp.481-489, 1994. ,
DOI : 10.1001/jama.264.14.1824
PHARMACOKINETICS OF TCDD IN VETERANS OF OPERATION RANCH HAND: 10-YEAR FOLLOW-UP, Journal of Toxicology and Environmental Health, vol.47, issue.3, pp.209-229, 1996. ,
DOI : 10.1080/009841096161744
Estimation of occupational exposure to 2,3,7,8-tetrachlorodibenzo-p-dioxin using a minimal physiologic toxicokinetic model, Environmental Health Perspectives, vol.106, issue.Suppl 2, pp.743-53, 1998. ,
DOI : 10.1289/ehp.98106743
PHARMACOKINETICS OF TCDD IN VETERANS OF OPERATION RANCH HAND: 10-YEAR FOLLOW-UP, Journal of Toxicology and Environmental Health, vol.47, issue.3, pp.369-78, 1999. ,
DOI : 10.1080/009841096161744
A physiologically based pharmacokinetic model for 2,3,7,8-tetrachlorodibenzo-p-dioxin in C57BL/6J and DBA/2J mice, Toxicology Letters, vol.42, pp.15-28, 1988. ,
Assessing the elimination of 2,3,7,8-TCDD from humans with a physiologically based pharmacokinetic model, Chemosphere, vol.17, issue.10, pp.2017-2044, 1988. ,
DOI : 10.1016/0045-6535(88)90012-4
A physiological pharmacokinetic description of the tissue distribution and enzyme-inducing properties of 2,3,7,8-tetrachlorodibenzo-p-dioxin in the rat, Toxicology and Applied Pharmacology, vol.103, issue.3, pp.399-410, 1990. ,
DOI : 10.1016/0041-008X(90)90313-J
Pharmacokinetics of [125I]-2-lodo-3,7,8-trichlorodibenzo-p-dioxin in mice: Analysis with a physiological modeling approach, Toxicology and Applied Pharmacology, vol.103, issue.3, pp.411-420, 1990. ,
DOI : 10.1016/0041-008X(90)90314-K
A Mechanistic Model of Effects of Dioxin on Gene Expression in the Rat Liver, Toxicology and Applied Pharmacology, vol.120, issue.1, pp.138-54, 1993. ,
DOI : 10.1006/taap.1993.1096
A Physiologically Based Pharmacokinetic Model for 2,3,7,8-Tetrabromodibenzo-p-dioxin (TBDD) in the Rat: Tissue Distribution and CYP1A Induction, Toxicology and Applied Pharmacology, vol.121, issue.1, pp.87-98, 1993. ,
DOI : 10.1006/taap.1993.1132
Modeling of the Toxicokinetics of Polychlorinated Dibenzo-p-dioxins and Dibenzofurans in Mammalians, Including Humans I. Nonlinear Distribution of PCDD/PCDF Body Burden between Liver and Adipose Tissues, Toxicology and Applied Pharmacology, vol.131, issue.2, pp.253-66, 1995. ,
DOI : 10.1006/taap.1995.1068
Modeling of the Toxicokinetics of Polychlorinated Dibenzo-p-dioxins and Dibenzofurans in Mammalians, Including Humans II. Kinetics of Absorption and Disposition of PCDDs/PCDFs, Toxicology and Applied Pharmacology, vol.131, issue.2, pp.267-76, 1995. ,
DOI : 10.1006/taap.1995.1069
A Mechanistic Model of Effects of Dioxin on Thyroid Hormones in the Rat, Toxicology and Applied Pharmacology, vol.136, issue.1, pp.29-48, 1996. ,
DOI : 10.1006/taap.1996.0004
Use of model-based compartmental analysis to study effects of 2,3,7,8-tetrachlorodibenzo-p-dioxin on vitamin A kinetics in rats, Toxicological Sciences, vol.44, pp.1-13, 1998. ,
Modeling Receptor-Mediated Processes with Dioxin: Implications for Pharmacokinetics and Risk Assessment, Risk Analysis, vol.11, issue.1, pp.25-36, 1993. ,
DOI : 10.1016/0045-6535(89)90430-X
Pharmacokinetic model of dioxin and furan levels in adipose tissue from Sawmill work involving chlorophenate fungicides, Chemosphere, vol.33, issue.12, pp.2373-81, 1996. ,
DOI : 10.1016/S0045-6535(96)00341-4
A pharmacokinetic analysis of interspecies extrapolation in dioxin risk assessment, Chemosphere, vol.35, issue.3, pp.427-52, 1997. ,
DOI : 10.1016/S0045-6535(97)00108-2
A Multicompartment Geometric Model of the Liver in Relation to Regional Induction of Cytochrome P450s, Toxicology and Applied Pharmacology, vol.144, issue.1, pp.135-179, 1997. ,
DOI : 10.1006/taap.1996.8066
Regional Hepatic CYP1A1 and CYP1A2 Induction with 2,3,7,8-Tetrachlorodibenzo-p-dioxin Evaluated with a Multicompartment Geometric Model of Hepatic Zonation, Toxicology and Applied Pharmacology, vol.144, issue.1, pp.145-55, 1997. ,
DOI : 10.1006/taap.1996.8067
Investigation of TCDD half-life heterogeneity in veterans of Operation Ranch Hand [published erratum appeared in the, Journal of Toxicology and Environmental Health Journal of Toxicology and Environmental Health, vol.36, issue.35, pp.29-38, 1992. ,
The estimation of elimination rates of persistent compounds: A re-analysis of 2,3,7,8-tetrachlorodibenzo-p-dioxin levels in Vietnam veterans, Chemosphere, vol.37, issue.9-12, pp.1833-1877, 1998. ,
DOI : 10.1016/S0045-6535(98)00249-5
Possible risk of endometriosis for Seveso, Italy, residents: an assessment of exposure to dioxin, Environmental Health Perspectives, vol.102, issue.5, pp.476-483, 1994. ,
DOI : 10.1289/ehp.94102476
Transposer de l'animal à l'humain : les modèles pharmacocinétiques physiologiques In: Science et Décision en Santé Environnementale -Les Enjeux de l'Evaluation et de la Gestion des Risques, pp.127-165, 1996. ,
An introduction to the use of physiologically based pharmacokinetic models in risk assessment, Statistical Methods in Medical Research, vol.91, issue.4, pp.341-58, 1997. ,
DOI : 10.1177/096228029700600404
Analysis of PBPK Models for Risk Characterization, Annals of the New York Academy of Sciences, vol.43, issue.9, pp.317-354, 1999. ,
DOI : 10.1016/0041-008X(90)90037-U
URL : https://hal.archives-ouvertes.fr/ineris-00962759
Physiologically Based Pharmacokinetic Modeling: Principles and Applications, Journal of Pharmaceutical Sciences, vol.72, issue.10, pp.1103-1130, 1983. ,
DOI : 10.1002/jps.2600721003
Extrapolation of a PBPK Model for Dioxins across Dosage Regimen, Gender, Strain, and Species, Toxicological Sciences, vol.56, issue.1, pp.49-60, 2000. ,
DOI : 10.1093/toxsci/56.1.49
Statistical Issues in Toxicokinetic Modeling: A Bayesian Perspective, Environmental Health Perspectives, vol.108, issue.s5, pp.883-93, 2000. ,
DOI : 10.1289/ehp.00108s5883
URL : https://hal.archives-ouvertes.fr/ineris-00961852
An Investigation of Uncertainty and Sensitivity Analysis Techniques for Computer Models, Risk Analysis, vol.83, issue.2, pp.71-90, 1988. ,
DOI : 10.1063/1.445400
Parameter variability and the interpretation of physiologically based pharmacokinetic modeling results, Environmental Health Perspectives, vol.102, issue.Suppl 11, pp.61-67, 1994. ,
DOI : 10.1289/ehp.94102s1161
MCSim: a simulation program, Journal of Statistical Software, vol.2, issue.9, 1997. ,
Food contamination by PCBs an dioxins, Nature, vol.401, issue.6750, pp.231-233, 1999. ,
DOI : 10.1038/45717
Applications of population approaches in toxicology, Toxicology Letters, vol.120, issue.1-3, pp.385-94, 2001. ,
DOI : 10.1016/S0378-4274(01)00270-3
URL : https://hal.archives-ouvertes.fr/ineris-00972203
The Belgian PCB/Dioxin Incident: Analysis of the Food Chain Contamination and Health Risk Evaluation, Environmental Research, vol.88, issue.1, pp.1-18, 2002. ,
DOI : 10.1006/enrs.2001.4274
Risk assessment of dioxin contamination in human food, Food and Chemical Toxicology, vol.40, issue.8, pp.1185-1194, 2002. ,
DOI : 10.1016/S0278-6915(02)00059-5
STRUCTURE AND QUANTIFICATION OF A PHYSIOLOGICAL MODEL OF THE DISTRIBUTION OF INJECTED AGENTS AND INHALED ANAESTHETICS, BJA: British Journal of Anaesthesia, vol.53, issue.4, pp.399-405, 1981. ,
DOI : 10.1093/bja/53.4.399
Gastrointestinal absorption of xenobiotics in physiologically based pharmacokinetic models, Drug Metabolism and Disposition, vol.19, pp.144-152, 1991. ,
Physiologically Based Pharmacokinetics and the Dermal Absorption of 2-Butoxyethanol Vapor by Humans, Fundamental and Applied Toxicology, vol.39, issue.2, pp.120-150, 1997. ,
DOI : 10.1006/faat.1997.2363
Mechanisms of benzene carcinogenesis: Application of a physiological model of benzene pharmacokinetics and metabolism, Toxicology Letters, vol.56, issue.3, pp.283-98, 1991. ,
DOI : 10.1016/0378-4274(91)90157-2
Markov chain Monte Carlo methods in biostatistics, Statistical Methods in Medical Research, vol.80, issue.4, pp.339-55, 1996. ,
DOI : 10.1177/096228029600500402
Physiological Pharmacokinetic Analysis Using Population Modeling and Informative Prior Distributions, Journal of the American Statistical Association, vol.55, issue.436, pp.1400-1412, 1996. ,
DOI : 10.2307/2533402